C. diff showdown: antibiotics vs. poop pills – which works better?
NCT ID NCT07374094
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 200 adults with C. diff infection to see how standard antibiotics and fecal microbiota transplantation (FMT) help people recover. Researchers will collect stool, blood, and urine samples over up to 5 years to understand why some treatments succeed and others fail. The goal is to improve future care for this serious gut infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Umeå University Hospital
RECRUITINGUmeå, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your dinner plate might fight c. diff: diet study aims to stop repeat infections
- FMT vs antibiotics: which works better Long-Term for c. diff?
- Hospital maps may slash infection spread
- New antibiotic CRS3123 takes on c. diff in early trial
- Gut bacteria capsules take on superbugs in antibiotic patients
- New drug combo shows promise against deadly gut infection